Document ID: chunk:federal_register_of_legislation:F2020L01377:reg:9:p2
Version: federal_register_of_legislation:F2020L01377
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 6706–7698

of the shoulder;
(14)      having a malignant neoplasm involving the region of the affected shoulder or the adjacent thoracic region, including the breast, within the one year before the clinical worsening of adhesive capsulitis of the shoulder;
(15)      having diabetes mellitus at the time of the clinical worsening of adhesive capsulitis of the shoulder;
(16)      having a thyroid disease from the specified list of thyroid diseases at the time of the clinical worsening of adhesive capsulitis of the shoulder;
Note: specified list of thyroid diseases is defined in the Schedule 1 - Dictionary.
(17)      having Parkinson's disease at the time of the clinical worsening of adhesive capsulitis of the shoulder;
(18)      taking highly active antiretroviral therapy for human immunodeficiency virus infection at the time of the clinical worsening of adhesive capsulitis of the shoulder;
(19)      inability to obtain appropriate clinical management for adhesive capsulitis of the shoulder.